The global immunoprecipitation market size was estimated to be USD 0.840 billion in 2023 and is expected to reach at USD 1.72 billion by 2034 with a CAGR of 6.78% during the forecast period 2024-2034. Rising prevalence of autoimmune disorders, increasing technological advancements in immunoprecipitation techniques, rising need for identifying antigens related to autoimmune diseases and developing relevant drugs, growing funding & investments from the government & non-government organizations on next-generation DNA sequencing & genomics research, growing prevalence of chronic disorders such as central nervous disorders, cancers, & cardiovascular diseases, and increasing collaborations within market players are some of the leading factors propelling the market growth.
Immunoprecipitation is a commonly used approach for purifying antigens, primarily employed to extract specific proteins from a complex mixture, such as a collection of cells or tissues. This method depends on the utilization of antibodies that specifically identify and attach to the target protein, facilitating the selective pull-down and purification of the desired antigen. Increasing collaborations within market players is predicted to boost the market growth during the forecast period. For instance, in March 2024, MilliporeSigma, the life sciences division of Merck, has entered into an agreement with BetterSeeds, an Israeli AgTech company specializing in genome editing technology, including CRISPR. This deal aims to showcase the agricultural applications of MilliporeSigma's CRISPR genome-editing tools and involves the licensing of its fundamental CRISPR intellectual property to BetterSeeds for the development of innovative plant breeds.
By product, kits was the highest revenue-grossing segment in the global immunoprecipitation market in 2023 owing to the need for recurring kit purchases, rising demand for IP assays for the isolation & purification of antigens, and growing initiatives from market players. For instance, in February 2022, MilliporeSigma, via its Sigma-Aldrich business, granted a license of its CRISPR-related intellectual property to the Israeli agricultural biotechnology company BetterSeeds for application in plants. Additionally, reagents is predicted to grow at the fastest CAGR during the forecast period owing to the growing need for agarose and magnetic beads in research laboratories, particularly for protein purification applications.
North America region is anticipated for the highest revenue share during the forecast period owing to the rise in investments & government funding, increasing awareness of personalized medicine, growing number of collaborations among key market players. For instance, in January 2022, The U.S. Government has approved the procurement of an additional 600,000 doses of sotrovimab, an investigational monoclonal antibody used for the early treatment of COVID-19, according to a statement released by GlaxoSmithKline plc and Vir Biotechnology, Inc. This approval guarantees broad accessibility to sotrovimab for patients nationwide. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the surge in biotechnology research, increasing awareness of personalized therapeutics, and growing number of partnerships among market leaders. For instance, in March 2023, Thermo Fisher Scientific has collaborated strategically with Arsenal Bio with the shared goal of advancing manufacturing processes for cutting-edge cancer treatments.
Immunoprecipitation is a commonly used approach for purifying antigens, primarily employed to extract specific proteins from a complex mixture, such as a collection of cells or tissues. This method depends on the utilization of antibodies that specifically identify and attach to the target protein, facilitating the selective pull-down and purification of the desired antigen. Increasing collaborations within market players is predicted to boost the market growth during the forecast period. For instance, in March 2024, MilliporeSigma, the life sciences division of Merck, has entered into an agreement with BetterSeeds, an Israeli AgTech company specializing in genome editing technology, including CRISPR. This deal aims to showcase the agricultural applications of MilliporeSigma's CRISPR genome-editing tools and involves the licensing of its fundamental CRISPR intellectual property to BetterSeeds for the development of innovative plant breeds.
By product, kits was the highest revenue-grossing segment in the global immunoprecipitation market in 2023 owing to the need for recurring kit purchases, rising demand for IP assays for the isolation & purification of antigens, and growing initiatives from market players. For instance, in February 2022, MilliporeSigma, via its Sigma-Aldrich business, granted a license of its CRISPR-related intellectual property to the Israeli agricultural biotechnology company BetterSeeds for application in plants. Additionally, reagents is predicted to grow at the fastest CAGR during the forecast period owing to the growing need for agarose and magnetic beads in research laboratories, particularly for protein purification applications.
By type, chromatin immunoprecipitation (ChIP) was the highest revenue-grossing segment in the global immunoprecipitation market in 2023 owing to the continuous technological advancements, increase in research studies aimed at developing enhanced protocols for chromatin immunoprecipitation. For instance, in March 2022, The T2T Consortium has released preliminary findings from the comprehensive assembly of the human genome. Researchers have detailed the genome sequence, genetic variations, epigenetic information, expression data, and other valuable insights obtained from a complete "telomere-to-telomere" (T2T) version of the human reference genome. Additionally, individual protein immunoprecipitation is predicted to grow at the fastest CAGR during the forecast period owing to the growing utilization of immunoprecipitation (IP) in the examination of protein-protein interactions, identification of antigen presence, and determination of the relative quantity of an antigen
By end-user, academic and research institutes was the highest revenue-grossing segment in the global immunoprecipitation market in 2023 owing to the increase in government funding, a rise in research & development investments by various market players, and a surge in the introduction of advanced devices. For instance, in June 2023, Thermo Fisher Scientific has unveiled the Thermo 6 Scanning Transmission Electron Scientific Metrios Microscope ((S)TEM), an advanced automated metrology solution designed to enhance efficiency and deliver top-quality data. It is especially beneficial for meeting the rigorous demands of high-volume semiconductor manufacturing. Additionally, contract research organizations (CROs) is predicted to grow at the fastest CAGR during the forecast period owing to rise in collaborations among market players and an increase in the outsourcing of research activities by prominent companies.North America region is anticipated for the highest revenue share during the forecast period owing to the rise in investments & government funding, increasing awareness of personalized medicine, growing number of collaborations among key market players. For instance, in January 2022, The U.S. Government has approved the procurement of an additional 600,000 doses of sotrovimab, an investigational monoclonal antibody used for the early treatment of COVID-19, according to a statement released by GlaxoSmithKline plc and Vir Biotechnology, Inc. This approval guarantees broad accessibility to sotrovimab for patients nationwide. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the surge in biotechnology research, increasing awareness of personalized therapeutics, and growing number of partnerships among market leaders. For instance, in March 2023, Thermo Fisher Scientific has collaborated strategically with Arsenal Bio with the shared goal of advancing manufacturing processes for cutting-edge cancer treatments.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
Study Coverage
- Market Forecast by Type, Material, Product, and End-user
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of Top 10+ Major Market Players
- 20% Free Customization Available to Meet Your Exact Requirement.
Segmentation: Immunoprecipitation Market Report 2023 - 2034
Immunoprecipitation Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Accessories
- Kits
- Reagents
- By Antibodies Type
- Primary Antibodies
- Secondary Antibodies
- By Beads Type
- Magnetic Beads
- Agarose Beads
Immunoprecipitation Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Bn)
- Co-Immunoprecipitation (Co-IP)
- RNA Immunoprecipitation (RIP)
- Chromatin Immunoprecipitation (ChIP)
- Individual Protein Immunoprecipitation
- Other
Immunoprecipitation Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Industries
- Contract Research Organizations (CRO's)
Immunoprecipitation Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Immunoprecipitation Market: Product Estimates & Trend Analysis
8. Immunoprecipitation Market: Type Estimates & Trend Analysis
9. Immunoprecipitation Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Immunoprecipitation Market
12. Europe Immunoprecipitation Market
13. Asia Pacific Immunoprecipitation Market
14. Latin America Immunoprecipitation Market
15. MEA Immunoprecipitation Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Biologics International Corp
- GenScript Biotech Corporation
- ProteinTech Group
- Bio-Rad Laboratories
- Cell Signalling Technology Inc.
- Abcam Plc
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Takara Bio Inc.
- Geno Technology Inc.
- Creative Proteomics
- Novus Biologicals
- Rockland Immunochemicals Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | March 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 0.84 Billion |
| Forecasted Market Value ( USD | $ 1.72 Billion |
| Compound Annual Growth Rate | 6.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
